Neonatal Blood Gas Interpretation

2016 ◽  
Vol 16 (3) ◽  
pp. 119-121 ◽  
Author(s):  
Ana Arias-Oliveras
Keyword(s):  
1999 ◽  
Vol 45 (6) ◽  
pp. 904-904
Author(s):  
C Morgan ◽  
S Newell ◽  
A Ducker ◽  
J Hodgkinson ◽  
D White ◽  
...  

1999 ◽  
Vol 80 (2) ◽  
pp. F93-F98 ◽  
Author(s):  
C Morgan ◽  
S J Newell ◽  
D A Ducker ◽  
J Hodgkinson ◽  
D K White ◽  
...  

1980 ◽  
Vol 97 (4) ◽  
pp. 650-652 ◽  
Author(s):  
Leland L. Fan ◽  
Kathleen T. Dellinger ◽  
Anita L. Mills ◽  
Robert E. Howard

2018 ◽  
Vol 108 (6) ◽  
pp. 1055-1060
Author(s):  
Kristin Tanney ◽  
Ajit Mahaveer ◽  
Karen Dockery ◽  
Nicola Booth ◽  
Carol A. Chadwick ◽  
...  

2021 ◽  
Vol 9 (36) ◽  
pp. 11330-11337
Author(s):  
Hai-Chuan Shen ◽  
Huan Wang ◽  
Bo Sun ◽  
Lan-Zhi Jiang ◽  
Qian Meng

1999 ◽  
Vol 27 (Supplement) ◽  
pp. 119A
Author(s):  
Colin Morgan ◽  
Simon Newell ◽  
Tony Ducker ◽  
Jane Hodgkinson ◽  
Deborah White ◽  
...  

1981 ◽  
Vol 99 (5) ◽  
pp. 833
Author(s):  
Gaetano Chirico ◽  
Giorgio Rondini

PEDIATRICS ◽  
1985 ◽  
Vol 75 (6) ◽  
pp. 1065-1067
Author(s):  
Keith J. Peevy ◽  
Michael W. Hall

Five years (1978 to 1982) of respiratory care data were reviewed to determine the changes in patient charges, hospital costs, and frequency of neonatal blood gas analysis created by the introduction of transcutaneous oxygen monitoring. During the 4 years of transcutaneous oxygen monitoring (1979 to 1982), an estimated $196,000 reduction in patient charges was accomplished. When reduced patient charges were balanced with the increased cost to the hospital for equipment, supplies, and personnel time, a net reduction of more than $100,000 for health care delivery was achieved. Transcutaneous oxygen monitoring is an example of technologic achievement in which society receives both economic and medical benefits.


Sign in / Sign up

Export Citation Format

Share Document